Title of article :
Structural requirement of chalcones for the inhibitory activity of interleukin-5 Original Research Article
Author/Authors :
Hyunmo Yang، نويسنده , , Hye-Rim Shin، نويسنده , , Soo-Hyun Cho، نويسنده , , Seong-Cheol Bang، نويسنده , , Gyu-Yong Song، نويسنده , , Jung-Hun Ju، نويسنده , , Mi-Kyeong Kim، نويسنده , , Seung-Ho Lee، نويسنده , , Jae Chun Ryu، نويسنده , , Youngsoo Kim، نويسنده , , Sang-Hun Jung، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Pages :
8
From page :
104
To page :
111
Abstract :
Novel chalcones were found as potent inhibitors of interleukin (IL)-5. 1-(2-Benzyloxy-6-hydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one (2b, 78.8% inhibition at 50 μM, IC50 = 25.3 μM) was initially identified as a potent inhibitor of IL-5. This shows the compatible activity with budesonide or sophoricoside. To identify structural requirements, 26 chalcones were prepared and their inhibitory activities were tested against IL-5. Among them, compound 4-[(E)-3-(2-cyclohexylmethoxy-6-hydroxyphenyl)-3-oxoprop-1-enyl]benzenesulfonamide (2w, 99.5% inhibition at 50 μM, IC50 = 1.8 μM) shows the most potent activity. The important structural requirements of these chalcone analogs exhibiting the inhibitory activity against IL-5 were recognized as the following. (1) The hydrophobic group such as benzyloxy or cyclohexylmethoxy at 6-position of A ring is necessary. (2) The existence of phenolic hydroxyl at 6-position of A ring is critical. (3) Propenone unit as α,β-unsaturated ketone is essential. (4) Electron withdrawing groups with hydrogen acceptor property at 4-position of B ring enhance the activity and quantitative structure–activity relationship of 2 regarding these substituents was determined.
Keywords :
Chalcones , Inhibitor , SAR , Interleukin-5
Journal title :
Bioorganic and Medicinal Chemistry
Serial Year :
2007
Journal title :
Bioorganic and Medicinal Chemistry
Record number :
1305256
Link To Document :
بازگشت